Skip to main content
. 2014 Mar 4;14:147. doi: 10.1186/1471-2407-14-147

Figure 1.

Figure 1

Overall survival (OS) and disease-specific survival (DSS) comparisons between neuroendocrine carcinoma (NEC) and invasive mammary carcinoma, not otherwise specified (IMC) diagnosed between 2003 and 2009. OS and DSS were significantly shorter in NEC than in IMC-NOS in both early stage disease (A and C) and advanced stage disease (B and D).